当前位置: 首页 > 期刊 > 《上海医药》 > 2011年第11期
编号:12127874
来氟米特对胶原性关节炎大鼠CD4+CD25+调节性T细胞的影响(3)
http://www.100md.com 2011年11月1日 《上海医药》 2011年第11期
     [6]Davis JP,Cain GA,Pitts WJ,et al. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase[J].Biochemistry,1996,35(4):1270-1273.

    [7]Gonzalez-Rey E,Fernandez-Martin A,Chorny A,et al. Vasoactive intestinal peptide induces CD4+CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis[J]. Arthritis Rheum,2006,54(3):864-876.

    [8]Frey O,Petrow PK,Gajda M,et al. The role of regulatory T cells in antigen-induced arthritis:Aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells [J].Arthritis Res Ther,2005,7(2):291-301.

    [9]Nadkarni S,Mauri C,Ehrenstein MR. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β[J].J Exp Med,2007,204(1):33-39.

    [10]Hori S,Nomura T,Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3[J].Science,2003,299(5609):1057-1061.

    [11]Valencia X,Stephens G,Goldbach-Mansky R,et al. TNF downmodulates the function of human CD4+CD25+ T-regulatory cells[J].Blood,2006,108(1):253-261.

    (收稿日期:2011-08-05), http://www.100md.com(王婷玉 李俊 金芝贵 吴飞华 金剑 汤亭亭)
上一页1 2 3